Catalyst Repository | Second Sight Medical Products Inc. Common Stock

Second Sight Medical Products Inc. Common Stock

(NASDAQ:EYES)

Description

Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. The company was founded in 1998 and is headquartered in Sylmar, California.

EYES Overview

None
Sector
Health Care
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus

Previous Close
$1.9210
Previous Close Volume
53800